UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
| |||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices, including Zip Code)
Registrant’s telephone number, including area code: (
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
The 2023 annual meeting of stockholders for Aytu BioPharma, Inc. was held on May 18, 2023 (the “2023 Annual Meeting”). Of the 3,778,722 shares outstanding on the record date for the meeting, a total of 1,942,164 shares were present or represented at the meeting. The matters voted on and the results of the votes at the 2023 Annual Meeting are as follows:
1. | Our stockholders elected five members to our board of directors as follows: |
Number of Votes Cast For | Number of Votes Withheld | Number of Broker Non-Votes | |||
Members |
|
|
|
|
|
Joshua R. Disbrow | 673,707 |
| 315,837 |
| 952,620 |
John A. Donofrio, Jr. | 677,912 | 311,632 | 952,620 | ||
Carl C. Dockery | 678,532 |
| 311,012 |
| 952,620 |
Vivian H. Liu | 685,411 | 304,133 | 952,620 |
2. | The approval of a new equity incentive plan for certain officers, directors, employees and other key personnel, the “2023 Equity Incentive Plan” was approved with 632,357 votes in favor, 352,359 votes against, and 4,828 abstentions. There were 952,620 broker non-votes. |
3. | The ratification of the appointment of Grant Thornton, LLC as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2023 was approved with 1,754,922 votes in favor, 132,135 votes against and 55,107 abstentions. |
4. | The advisory vote on executive compensation was approved with 587,253 votes in favor, 383,698 votes against and 18,593 abstentions. There were 952,620 broker non-votes. |
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit |
| Description |
104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document) |
Document and Entity Information |
May 18, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | May 18, 2023 |
Entity File Number | 001-38247 |
Entity Registrant Name | AYTU BIOPHARMA, INC. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 47-0883144 |
Entity Address, Address Line One | 373 Inverness Parkway |
Entity Address, Adress Line Two | Suite 206 |
Entity Address, City or Town | Englewood |
Entity Address, State or Province | CO |
Entity Address, Postal Zip Code | 80112 |
City Area Code | 720 |
Local Phone Number | 437-6580 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | AYTU |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001385818 |
Amendment Flag | false |
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end
EOF<>WQ\K^]UYU?;LD"_J%1,\(L@C9( 44Y$SOCJ(JA5B!5A++BZ
M?/UJ_B8,GZX?[E N2%U2KA&1%&N:HPW3:_0HJ@IS=$^E9$6!KB7+5Q2A-(FR
M:!)-41BV&M=808S@R(IE4=HA[UL]P6=H$J?3.$NR,Y2FLTDZRS+TY;YCWH/!
M)7N9NE7Y3)$U+3'26*ZH_H1+JBI,Z$6PUKJ:Q?%FLXGPLZX73$1$E%8HF:1O
M X2UEFQ1:_I1R/*&+G%=:,@)_UGCPNX.J2JHR81'V(,AMUS-P(2WV^8L$G(%
M&R5I_'1_]]7Z A3%;NSO=[Y3.K504^GY?KNQW_S1IT20J9-1^N8 & [D]*'MCT@/FJ0,3JE ^Q^R$1WX*\/J'<_[/+6OOV;0->@3A)(8=B
M#DI2ZA93.>R:44C CMUS2R9,&?%V#>H!::;O9*$CY%/'MM _(O\O:<&UUH+'
MD5(KL0?)_X6L'&DWG_DI:=0B8.$AOQH33E.#.E; 71U+3(P,C,P
M-3$X+GAS9%!+ 0(4 Q0 ( A ME;!)B]-=@4 &X^ 5
M " :(# !A>71U+3(P,C,P-3$X7VQA8BYX;6Q02P$"% ,4 " (0+96
M 3- ]($$ "#)P %0 @ %+"0 87ET=2TR,#(S,#4Q.%]P
MM=N_Z%?PF>U[GR.KX/_:>-
M\DDT.,:'I3$F_W7DGY$8%$14DG16";YM33F?=UQWN5RVEY=MRB;"X,)SOSWU
M!N$4S0('DX0')$0M$/I.DK[9HV' TWG:V7TU8K$RN'0W8QD5\I6C9(Y\R_%\
MY])KKY*HE;>B%;O'-):D/P1Q+\,:7Z(LWRE#*'S^]=/<1